Clinical Trials Browser

Lymphoma × sapanisertib × Clear all

NCT06390865 2025-11-04

Testing MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With TSC1 or TSC2 Genetic Changes (MATCH - Subprotocol M)

Phase 2 Active not recruiting

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT02727777 2020-03-12

Phase II Study of TAK228 in Relapsed Lymphoma

Phase 1/2 Terminated

4 enrolled 9 charts

Lymphoma